The name trypanophobia is a combination of the Greek word trypano, which means piercing or puncturing, with a phobia. This common condition is marked by extreme fear or aversion to blood or needles. It’s projected almost 25% of adults have this phobia which might lead 16% of the US population to skip vaccinations. Numerous people who ear needle sticks may evade doctors and medicinal care, so it’s possible that the extent of this problem is undervalued.
The needle-free injection systems market was sized at $151 million in 2021 and will grow at a rate of about 13% by the end of this decade, to generate $466 million by 2030. This is due to the global increasing diabetic population, generating high demand for self-injection instruments; snowballing prevalence of needlestick injuries; and the people fearing needles.
The technology, which is jet-based has the highest demand in the needle-free injection systems market, and this will expand with a growth rate of approximately 14% during the forecast period. This is due to the numerous benefits including a smaller amount of time spent on preparation and administering the medication, fewer needlestick injuries, ease in usage and esthetics, and a less chance of a disease spread.
Needle-free injection systems are exceedingly used for the delivery of insulin. This is because of the huge diabetic population using a large count of insulin delivery devices and the fear of syringes or needles among people. Additionally, with no risk of a needlestick injury, it is a feasible option for home use and also in healthcare settings. Accordingly, the demand for needle-free injectors is increasing for insulin delivery, and so is the revenue of the needle-free injection systems market in the current scenario.
The increasing demand for needle-free injections is mainly due to a large number of people fearing needles and an increasing count of patients suffering from diabetes.
